Kevin Crona, Pharm D
About Kevin Crona, Pharm D
Kevin Crona, PharmD, is the Associate Director of Business Development Analytics at Bristol Myers Squibb, with prior experience at Bayer Pharmaceuticals and a background in pharmacy and business development.
Current Role at Bristol Myers Squibb
Kevin Crona, PharmD, currently holds the position of Associate Director, Business Development Analytics at Bristol Myers Squibb. In this role, he focuses on business development activities, utilizing his pharmaceutical expertise and analytical skills to support the company's growth and strategic initiatives.
Previous Experience at Bayer Pharmaceuticals
Kevin Crona previously worked at Bayer Pharmaceuticals, where he served in multiple roles. From 2020 to 2021, he was the Senior Manager of Valuation, New Business Development and Licensing, where he was responsible for assessing the financial value and potential of new business ventures. Prior to this, he worked as a Business Development and Licensing Associate from 2018 to 2020, contributing to business development and partnership activities.
Education and Qualifications
Kevin Crona holds a Doctor of Pharmacy (PharmD) degree from the University of Michigan. Additionally, he earned a Bachelor of Science (BS) in Biology from the University of Colorado. His educational background provides a strong foundation in both the life sciences and clinical research, equipping him with the skills necessary for his roles in the pharmaceutical industry.
Pharmacy Internships and Externships
Kevin Crona gained extensive experience in the field of pharmacy through several intern roles. He served as a Pharmacy Intern at the University of Michigan Medical Center and University of Michigan Homecare Services from 2015 to 2018, where he gained hands-on clinical and homecare experience. Additionally, he worked as a Pharmacy Extern at Catalyst Regulatory Services in Dexter, MI in 2017.
Investment Consultancy at Maize and Blue Endowment Fund
From 2017 to 2019, Kevin Crona worked as an Investment Consultant at the Maize and Blue Endowment Fund at the University of Michigan Ross School of Business. In this role, he provided financial insights and contributed to the management of the endowment fund, blending his pharmaceutical knowledge with financial acumen.